These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1395819)

  • 1. Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects.
    Hirsh J; Dalen JE; Fuster V; Harker LB; Salzman EW
    Chest; 1992 Oct; 102(4 Suppl):327S-336S. PubMed ID: 1395819
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticoagulant, antiplatelet agents].
    Ishikawa K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():647-53. PubMed ID: 12735045
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
    Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary and secondary prevention of ischemic cerebrovascular accidents of arteriosclerosis by platelet inhibitors].
    Rosa A; Canaple S
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1563-8. PubMed ID: 9092419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
    Iturbe T; Sánchez C; Moreno JA; Olave T; Azaceta G; Varo MJ; Civeira E; Peleato J; Cornudella R
    Sangre (Barc); 1997 Oct; 42(5):387-90. PubMed ID: 9424739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
    Sauer H; Leschke M
    Dtsch Med Wochenschr; 2006 Feb; 131(8):400-2. PubMed ID: 16479474
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.
    Mohammad RA; Goldberg T; Dorsch MP; Cheng JW
    Clin Ther; 2010 Dec; 32(14):2265-81. PubMed ID: 21353100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plavix isn't for everyone. Adding Plavix to aspirin doesn't help people without heart disease.
    Harv Heart Lett; 2006 Jun; 16(10):1. PubMed ID: 16791939
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antiplatelet agents--problem for cardiac surgeon].
    Bochenek A; Wilczyński M
    Kardiol Pol; 2006 Nov; 64(11):1329-31. PubMed ID: 17165174
    [No Abstract]   [Full Text] [Related]  

  • 11. [Secondary prevention of cerebral ischemia. AMEVASC. Mexican Association of Cerebrovascular Disease].
    Barinagarrementeria F; Amaya L; Guzmán JL; Ibarra O; Loy Mdel C; Millán R; Neri G; Villarreal J; Araúz A; Cantú C
    Rev Invest Clin; 2002; 54(3):257-61. PubMed ID: 12183895
    [No Abstract]   [Full Text] [Related]  

  • 12. Clopidogrel/aspirin combination therapy in high-risk atrial fibrillation patients.
    Cardiovasc J Afr; 2009; 20(3):210. PubMed ID: 19575095
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention and therapy with anticoagulants. Indications, experiences, results].
    Bruhn HD
    Intensivmed Prax; 1979; (2):91-7. PubMed ID: 553881
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: Anticoagulation IV: Preventing thrombosis by modifying platelet behavior.
    Adelson E; Segal A
    Med Ann Dist Columbia; 1974 Jun; 43(6):7-8. PubMed ID: 4526259
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcomes associated with combined antiplatelet and anticoagulant therapy.
    Johnson SG; Rogers K; Delate T; Witt DM
    Chest; 2008 Apr; 133(4):948-54. PubMed ID: 18198244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
    Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
    [No Abstract]   [Full Text] [Related]  

  • 18. Medications used to prevent adhesion and clotting.
    Lassiter TF
    Lippincotts Prim Care Pract; 2000; 4(6):619-32; quiz 633-5. PubMed ID: 11933375
    [No Abstract]   [Full Text] [Related]  

  • 19. Secondary prevention of myocardial infarction in the first European Stroke Prevention Study.
    Lowenthal A
    Thromb Res Suppl; 1990; 12():59-63. PubMed ID: 2082489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.
    Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.